Broad and systemic immune-modulating capacity of plant-derived dsRNA. (1st August 2019)

• Record Type: Journal Article
• Authors: Hajake, Takara; Matsuno, Keita; Kasumba, Dacquin M; Oda, Haruka; Kobayashi, Moe; Miyata, Nao; Shinji, Madoka; Kogure, Amane; Kasajima, Nodoka; Okamatsu, Masatoshi; Sakoda, Yoshihiro; Kato, Hiroki; Fujita, Takashi
• Is Part Of: International immunology. Volume 31:Number 12(2019)
• Page Start: 811
• Page End: 821
• Publication Date: 2019-08-01
• Subjects: adjuvant -- anti-viral -- double-stranded RNA -- melanoma -- type I interferon; Immunology -- Periodicals; 616.079
• DOI: 10.1093/intimm/dxz054
• Languages: English
• ISSNs: 0953-8178

Abstract

Abstract : Plant-derived endornavirus dsRNA enhances a variety of immune responses Abstract: Double-stranded RNA (dsRNA) is well characterized as an inducer of anti-viral interferon responses. We previously reported that dsRNA extracted from a specific edible plant possesses an immune-modulating capacity to confer, in mice, resistance against respiratory viruses, including the H1N1 strain of the influenza A virus (IAV). We report here that the systemic immune-activating capacity of the plant-derived dsRNA protected mice from infection by a highly virulent H5N1 strain of the IAV. In addition, subcutaneous inoculation of the dsRNA together with the inactivated virion of the H5N1 strain of the IAV suppressed the lethality of the viral infection as compared with individual inoculation of either dsRNA or HA protein, suggesting its potential usage as a vaccination adjuvant. Moreover, intra-peritoneal inoculation of the dsRNA limited the growth of B16-F10 melanoma cells through the activation of NK cells in murine models. Taken together, this study demonstrated the systemic immune-modulating capacity of a plant-derived dsRNA and its potential for nucleic acid-based clinical applications.